PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Bibliografiset tiedot
Päätekijät:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Aineistotyyppi:	Artikkeli
Kieli:	Russian
Julkaistu:	Remedium Group LLC 2017-11-01
Sarja:	Медицинский совет
Aiheet:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Linkit:	https://www.med-sovet.pro/jour/article/view/2007

Samankaltaisia teoksia

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
Tekijä: Annina S. Vischer, et al.
Julkaistu: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
Tekijä: Chinonyerem O. Iheanacho, et al.
Julkaistu: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
Tekijä: Piotr Skonieczny, et al.
Julkaistu: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
Tekijä: Yang Zhao, et al.
Julkaistu: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
Tekijä: Chibuike C. Udenigwe, et al.
Julkaistu: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
Tekijä: Kuang-Ming Liao, et al.
Julkaistu: (2023-11-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Tekijä: Jordan Loader, et al.
Julkaistu: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
Tekijä: Simon B. Gressens, et al.
Julkaistu: (2021-02-01)

Angiotensins and rheumatoid arthritis
Tekijä: N. M. Savushkina, et al.
Julkaistu: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
Tekijä: JungMin Choi, et al.
Julkaistu: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
Tekijä: Leonard K. Wang, et al.
Julkaistu: (2023-06-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
Tekijä: N. V. Drobotya, et al.
Julkaistu: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
Tekijä: Yipeng Fang, et al.
Julkaistu: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
Tekijä: Jilong XU, et al.
Julkaistu: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
Tekijä: Anna V. Aksenova, et al.
Julkaistu: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
Tekijä: S. V. Stolov
Julkaistu: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
Tekijä: Konstantinos Tziomalos, et al.
Julkaistu: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
Tekijä: T E Morozova
Julkaistu: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
Tekijä: K. A. Ghyamdzhyan, et al.
Julkaistu: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
Tekijä: Stine Andersen, et al.
Julkaistu: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
Tekijä: S Ravitej, et al.
Julkaistu: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
Tekijä: Hye-Jin Park, et al.
Julkaistu: (2022-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
Tekijä: Ann Z. Bauer, et al.
Julkaistu: (2021-01-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
Tekijä: Steven M. Smith, et al.
Julkaistu: (2023-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
Tekijä: Joachim Beige
Julkaistu: (2019-06-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Tekijä: Maksimov M.L., et al.
Julkaistu: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Tekijä: M L Maksimov, et al.
Julkaistu: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
Tekijä: Hany A Al-Hussaniy, et al.
Julkaistu: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
Tekijä: Yohko Nagai, et al.
Julkaistu: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
Tekijä: M L Maksimov
Julkaistu: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
Tekijä: Kamryn E. Jones, et al.
Julkaistu: (2024-06-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
Tekijä: Odifentse Mapula-e Lehasa, et al.
Julkaistu: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
Tekijä: Mishita Goel, et al.
Julkaistu: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
Tekijä: A. E. Bragina, et al.
Julkaistu: (2005-12-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
Tekijä: Tao Liu, et al.
Julkaistu: (2023-01-01)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
Tekijä: Marcin Zeman, et al.
Julkaistu: (2022-07-01)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
Tekijä: Byoung Geol Choi, et al.
Julkaistu: (2016-07-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
Tekijä: S. G. Kanorskiy
Julkaistu: (2021-04-01)

Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study
Tekijä: Minji Jung, et al.
Julkaistu: (2024-11-01)

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
Tekijä: Gemma García-Lluch, et al.
Julkaistu: (2023-03-01)